Deflux的封面图片
Deflux

Deflux

医疗设备制造业

Santa Barbara,CA 659 位关注者

Deflux? is the only FDA-approved injectable treatment for vesicoureteral reflux (VUR) grades II-IV.

关于我们

Deflux? injectable gel - the only FDA-approved injectable treatment of vesicoureteral reflux. VUR is a malformation of the urinary bladder that affects 1% of children. (1) Deflux gel has been in use for over two decades to treat children with VUR. (2) VUR occurs when the connection between the bladder and ureter is atypical. The lower part of the ureter tunnels through the muscle of the bladder. If this tunnel is too short or is located too much to one side, VUR may occur. These infections can lead to scarring and damage to the kidneys, which can lead to poor kidney function and high blood pressure later in life. Swift treatment helps minimize the risk of long-term kidney damage. The HA in Deflux treatment has been used in more than 50 million procedures worldwide (2), often as a dermal filler for wrinkle correction. Deflux treatment works well to stop VUR in children. Many children have success after one injection, while some may need more injection procedures. Deflux gel has been proven effective in up to 93% of children with VUR grades II-IV(3). Learn more about Deflux Injectable Gel at: https://www.deflux.com/hcp/ References: 1. Hensle TW, Grogg AL. Vesicoureteral reflux treatment: the past, present and future. Challenges surrounding vesicoureteral reflux: fuel for a paradigm shift in treatment. Curr Med Res Opin. 2007;23(Suppl 4):S1-S6. 2. Galderma. Restylane. Available at: https://www.galderma.com/uk/restylane. Accessed September 1, 2020. 3. Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ. Intermediate to long-term follow-up indicates low risk of recurrence after double hit endoscopic treatment for primary vesicoureteral reflux. J Pediatr Urol. 2012;8(4):359-365

网站
https://www.deflux.com
所属行业
医疗设备制造业
规模
超过 10,001 人
总部
Santa Barbara,CA
创立
2001
领域
Pediatric Urology

动态

关联主页

相似主页